Value-Based Pharmaceutical Contracts: Value for Who?

Value-based pharmaceutical contracts (VBPCs) are performance-based reimbursement agreements between healthcare payors and pharmaceutical manufacturers in which the price, amount, or nature of reimbursement is tied to value-based outcomes. VBPCs are often complex, and the nature of who benefits and in what ways can be unclear. We discuss how VBPCs compare with value-based payor –provider arrangements in terms of performance-based reimbursements and alignment of incentives. In addition, we examine how VBPCs can affect costs, clinical outcomes, and access to medications.

Source: Value in Health - December 4, 2019 Category: International Medicine & Public Health Authors: Joseph T. Kannarkat, Chester B. Good, Natasha Parekh Source Type: research